Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2021
Pamiparib: First Approval.
Anthony Markham
PubMed ↗
Publisher ↗
No numbers read from the abstract.
37 papers cite it
2021
2022
2023
2024
2025
2026
this paper
pooled it
trial
cites it
The trial
NCT03333915
phase 1/phase 2
128 enrolled
2016
Pamiparib: First Approval. | OpenQuestion